Edwards Lifesciences stock heads into the open after market drop

At the close on September 23, 2026, Edwards Lifesciences stock had a documented NYSE opening price of USD 88.81, while the S&P 500 fell 0.8 percent to 7,706.03. U.S. bond yields and oil prices pressured equities.

Edwards Lifesciences stock had a documented opening price of USD 88.81 on the NYSE on September 23, 2026. The broader U.S. market fell that session, with the S&P 500 down 0.8 percent to 7,706.03.

September 23, 2026 in numbers

Edwards Lifesciences Corporation (ISIN US28176E1082, NYSE: EW) opened at USD 88.81 on September 23, 2026, according to MarketBeat. The same source reported a market capitalization of USD 51.14 billion and a 52-week range from USD 72.30 to USD 96.29.

As ABC News reported, the S&P 500 fell 58.61 points to 7,706.03, while the Nasdaq Composite dropped 308.24 points, or 1.1 percent, to 26,936.04. The session backdrop included a rise in the 10-year Treasury yield to 5.11 percent after stronger economic data increased inflation concerns.

September 24, 2026 outlook

Market conditions remain the directly substantiated consideration for the stock ahead of the U.S. open. The medical technology sector may be affected by broader equity pressure and higher bond yields, but the available dated evidence does not establish a separate Edwards Lifesciences catalyst for September 24, 2026.